MAKING BIOTECHNOLOGY WORK

MAKING BIOTECHNOLOGY WORK FOR THE PUBLIC GOOD

Technology Analyst. Business Strategist. New Product Developer. Public Health Innovator.

For over 25 years I have been driven through my research and industry work to build and advance biotechnology solutions for complex problems impacting health and the environment. Currently working to advance new technologies with public health, biosecurity, and environmental applications.

Previous Companies
  • Intrexon | pioneering synthetic biology and genetic engineering company
  • Exonhit Therapeutics | microarray molecular diagnostics for chronic disease and genetic variant screening
  • Vectrant Technologies | biodefense threat detection systems and infectious disease medical diagnostics
  • Nanogen | microarray molecular diagnostics for chronic and infectious diseases
  • Gen-Probe | molecular tests for screening US blood supply and clinical diagnostics for infectious diseases

Highlights

  • Advanced first-in-class genetic engineering products and new product development programs for health, food, consumer, biosecurity, and environment sectors at pioneering synthetic biology company (Intrexon) (see list)
  • Pioneered gene-edited bioremediation platform for environmental cleanup of contaminants of concern (Intrexon)
  • Supported diligence and business strategy for biotechnology acquisitions exceeding $400M (Intrexon) (see list)
  • Developed novel molecular diagnostics and environmental biothreat detection systems with integrated immunoassay and molecular tests for US Intelligence Community (Vectrant)
  • Launched the APTIMA infectious disease molecular diagnostic platform with first FDA-cleared combined chlamydia and gonorrhea test (Gen-Probe)
  • Developed molecular tests for safety screening of US blood supply against HIV, HCV, HBV, and West Nile Virus (Gen-Probe)
  • Developed several first-in-class molecular diagnostics at leading diagnostics company (Gen-Probe) and have specialized experience developing FDA regulated medical diagnostics (see list)